Abstract:

Cerebroconvex meningioma is a common incidental brain tumor, accounting for approximately 15% to 25% of intracranial meningiomas. The optimal treatment plan for convex meningioma is currently controversial, and the recent advances in the biology and imaging studies of meningiomas allow for precise individualized clinical risk stratification of patients, which can guide decisions regarding imaging monitoring, surgery, and postoperative radiotherapy. An individualized approach can be used in clinical work to balance aggressive total tumor resection and the protection of adjacent neurofunctional structures, while considering the patient's own physical conditions, meningioma-specific factors (e.g., meningioma biology, specific location, and imaging features), and the possibility of radiotherapy. The stratified approach to the management of convexity meningiomas is highly individualized, taking into account the patient's age, life expectancy, current neurological status, natural history of the meningioma, priority of other concomitant diseases, and involves comprehensive decision-making around treatment goals, durability of tumor control, adverse events, and quality of life of the patient after different management measures. This article mainly reviews the personalized full process management of cerebral convex meningioma.

Key words: Convexity meningiomas, Individualized full process management, Surgical treatment, Radiation therapy